← SynDRA
DAPSONE
SynDRA canonical compound SYN0003328 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | DHFR |
|---|
| Mechanism of action | Bacterial antifolate |
|---|
| Indication | dermatitis herpetiformis (DH) | leprosy |
|---|
| Disease area | dermatology | infectious disease |
|---|
All known targets
- DHFR
- CYP3A4
- G6PD
- HTR6
- MPO
- PC DHPS
- PPPK-DHPS
- TAS2R40
- folP1
Mechanisms of action (all sources)
- Bacterial antifolate
- TAS2R40 AGONIST
- PC DHPS MODULATOR
- folP1 INHIBITOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ADORA1
- PDE3A
- OPRK1
- OPRD1
- NR3C1
- NR1I2
- NPY1R
- MLNR
- MDH1
- MC4R
- MC3R
- MBNL1
- MAOA
- LMNA
- KCNH2
- HTR3A
- HTR2C
- OPRM1
- PDE4D
- HTR2A
- PGR
- UGT1A4
- UGT1A1
- TSHR
- TDP1
- TBXA2R
- SMAD3
- SLCO1B3
- SLCO1B1
- SLC6A4
- SLC6A3
- SLC6A2
- SLC29A1
- RORC
- PTGS2
- PRF1
- HTR2B
- HTR1A
- ADORA2A
- CHRM3
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Drug classes
- Anti-Bacterial Agents
- Anti-Infective Agents
- Antimalarials
- Antiparasitic Agents
- Antiprotozoal Agents
- Enzyme Inhibitors
- Folic Acid Antagonists
- Leprostatic Agents
- Sulfone
ATC classes
- J04B · DRUGS FOR TREATMENT OF LEPRA
- D10A · ANTI-ACNE PREPARATIONS FOR TOPICAL USE
Cross-references
Synonyms
- ACZONE
- Aczone
- diaphenylsulfon
- diaphenylsulfone
- sulphadione
- dapson
- Diaphenylsulfone
- Dapsona
- Dapsonum
- Diaminodiphenylsulfone
- Novophone
- Servidapson
- J04BA02
- NSC-6091
- NSC-6091D
- Atrisone
- Avlosulfon
- Avlosulfone
- Avlosulphone
- Avsulfor
- Croysulfone
- Croysulphone
- DADPS
- DDS
- Dapson
- Diaminodifenilsulfona
- Diaphenylsulfon
- Diaphenylsulphon
- Diaphenylsulphone
- Diphenasone
- Diphone
- Disulone
- Dubronax
- Dubronaz
- Dumitone
- Eporal
- Protogen
Reported adverse events
- Pruritus
- Headache
- Abdominal pain
- Cough
- Erythema
- Influenza
- Nasopharyngitis
- Pharyngitis
- Pyrexia
- Sinusitis
- Suicide attempt
Look up DAPSONE in the interactive SynDRA portal →